TGF-β-FOXO signaling pathway is involved in the maintenance of leukemia-initiating cells in CML, contributing to intrinsic resistance of CML LSCs to tyrosine kinase inhibitor [42, 43]. The gene discussed is TGFB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.